Clinical Trial Update: Plasma Modifications Associated With Rivaroxaban® Treatment for Stroke Prevention

View source ↗

Summary

This clinical trial update reports plasma modifications associated with rivaroxaban treatment for stroke prevention in atrial fibrillation. The trial status is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Xarelto (rivaroxaban)

Snippet

Sponsor: Centre Hospitalier Universitaire de Nīmes | Conditions: Atrial Fibrillation | Status: COMPLETED